Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring: the randomized controlled FK04 trial

被引：0
|
作者：
Ruijter, B. [1 ]
Tushuizen, M. [1 ]
Moes, D. -J. [2 ]
de Klerk, B. [1 ]
van Hoek, B. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Gastroenterol & Hepatol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Clin Pharmacol & Toxicol, Leiden, Netherlands
来源：
TRANSPLANTATION | 2023年 / 107卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
EP-295
引用
收藏
页码：215 / 215
页数：1
相关论文
共 45 条
  • [31] 12-month follow-up analysis of a multicenter, randomized, prospective trial in de Novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus
    Levy, Gary
    Grazi, Gian Luca
    Sanjuan, Fernando
    Wu, Youmin
    Muehlbacher, Ferdinand
    Samuel, Didier
    Friman, Styrbjorn
    Jones, Robert
    Cantisani, Guido
    Villamil, Federico
    Cillo, Umberto
    Clavien, Pierre Alain
    Klintmalm, Goran
    Otto, Gerd
    Pollard, Stephen
    McCormick, P. Alden
    Grp, LIS2T Study
    LIVER TRANSPLANTATION, 2006, 12 (10) : 1464 - 1472
  • [32] FIVE-YEAR ON-TREATMENT SYSTEMATICALLY MONITORING OF DYNAMIC CHANGES OF LIVER STIFFNESS MEASUREMENT WITH TRANSIENT ELASTOGRAPHY COMPARED WITH PAIRED LIVER BIOPSIES IN A RANDOMIZED CONTROLLED TRIAL IN CHRONIC HEPATITIS B PATIENTS
    Sun, J.
    Xie, Q.
    Tan, D.
    Ning, Q.
    Niu, J.
    Bai, X.
    Fan, R.
    Liang, X.
    Chen, S.
    Cheng, J.
    Yu, Y.
    Wang, H.
    Xu, M.
    Shi, G.
    Wan, M.
    Chen, X.
    Tang, H.
    Sheng, J.
    Dou, X.
    Shi, J.
    Ren, H.
    Wang, M.
    Zhang, H.
    Gao, Z.
    Chen, C.
    Ma, H.
    Chen, Y.
    Jia, J.
    Hou, J.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S133 - S134
  • [33] IMPACT OF GLUCOSE SELF-MONITORING ON NON-INSULIN-TREATED PATIENTS WITH TYPE-II DIABETES-MELLITUS - RANDOMIZED CONTROLLED TRIAL COMPARING BLOOD AND URINE TESTING
    ALLEN, BT
    DELONG, ER
    FEUSSNER, JR
    DIABETES CARE, 1990, 13 (10) : 1044 - 1050
  • [34] Efficacy of intermittent short-term use of a real-time continuous glucose monitoring system in non-insulin-treated patients with type 2 diabetes: A randomized controlled trial
    Moon, Sun Joon
    Kim, Kyung-Soo
    Lee, Woo Je
    Lee, Mi Yeon
    Vigersky, Robert
    Park, Cheol-Young
    DIABETES OBESITY & METABOLISM, 2023, 25 (01): : 110 - 120
  • [35] Effects of oleoylethanolamide supplementation on the expression of lipid metabolism-related genes and serum NRG4 levels in patients with non-alcoholic fatty liver disease: A randomized controlled trial
    Tutunchi, Helda
    Ebrahimi-Mameghani, Mehrangiz
    Hosseinzadeh-Attar, Mohammad Javad
    Roshanravan, Neda
    Mobasseri, Majid
    Najafipour, Farzad
    Naeini, Fatemeh
    Naghshi, Sina
    Asghari, Samira
    Akbarzadeh, Moloud
    Soleimanzadeh, Hamid
    Ostadrahimi, Alireza
    CLINICAL NUTRITION ESPEN, 2023, 58 : 311 - 319
  • [36] Subject-driven titration of biphasic insulin aspart 30 twice daily is non-inferior to investigator-driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open-label, parallel-group, multicenter trial
    Yang, Wenying
    Zhu, Lvyun
    Meng, Bangzhu
    Liu, Yu
    Wang, Wenhui
    Ye, Shandong
    Sun, Li
    Miao, Heng
    Guo, Lian
    Wang, Zhanjian
    Lv, Xiaofeng
    Li, Quanmin
    Ji, Qiuhe
    Zhao, Weigang
    Yang, Gangyi
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (01) : 85 - 93
  • [37] Glucose Exposure and Variability with Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes: Continuous Glucose Monitoring Data from a 4-Week, Randomized, Placebo-Controlled Trial (EASE-1)
    Famulla, Susanne
    Pieber, Thomas R.
    Eilbracht, Jens
    Neubacher, Dietmar
    Soleymanlou, Nima
    Woerle, Hans J.
    Broedl, Uli C.
    Kaspers, Stefan
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (01) : 49 - 60
  • [38] Improved glycemic control after the use of flash glucose monitoring accompanied by improved treatment satisfaction in patients with non-insulin-treated type 2 diabetes: A post-hoc analysis of a randomized controlled trial
    Hayase, Ayaka
    Onoue, Takeshi
    Kobayashi, Tomoko
    Wada, Eri
    Handa, Tomoko
    Kinoshita, Tamaki
    Yamagami, Ayana
    Yasuda, Yoshinori
    Iwama, Shintaro
    Kawaguchi, Yohei
    Miyata, Takashi
    Sugiyama, Mariko
    Takagi, Hiroshi
    Hagiwara, Daisuke
    Suga, Hidetaka
    Banno, Ryoichi
    Kuwatsuka, Yachiyo
    Ando, Masahiko
    Goto, Motomitsu
    Arima, Hiroshi
    PRIMARY CARE DIABETES, 2023, 17 (06) : 575 - 580
  • [39] Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)
    Meertens, Marinda
    Muntinghe-Wagenaar, M. Benthe
    Sikkema, Barend J.
    Lopez-Yurda, Marta
    Retel, Valesca P.
    Paats, Marthe S.
    Ter Heine, Rob
    Schuuring, Ed
    Timens, Wim
    Touw, Daan J.
    van Boven, Job F. M.
    de Langen, Adrianus. J.
    Hashemi, Sayed M. S.
    Hendriks, Lizza E. L.
    Croes, Sander
    van den Heuvel, Michel M.
    Dingemans, Anne-Marie C.
    Mathijssen, Ron H. J.
    Smit, Egbert F.
    Huitema, Alwin D. R.
    Steeghs, Neeltje
    van der Wekken, Anthonie J.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [40] EFFECT OF HOME BLOOD PRESSURE TELE-MONITORING PATHWAY WITH PHARMACIST CASE MANAGEMENT TO SUPPORT PATIENTS DISCHARGED FROM EMERGENCY DEPARTMENT WITH ASYMPTOMATIC HYPERTENSION: A STUDY PROTOCOL FOR MULTICENTRE RANDOMIZED CONTROLLED TRIAL (TEC4HOME-BP)
    Tran, Karen
    Kuyper, Laura
    Mangat, Birinder
    Ringrose, Jennifer
    Kim-Sing, Chad
    Lindsay, Heather
    Dahri, Karen
    Dawes, Martin
    Wong, Hubert
    Coderio, Jennifer
    Mak, Meagan
    Novak-Lauscher, Helen
    Khan, Nadia
    Ho, Kendall
    JOURNAL OF HYPERTENSION, 2024, 42 (SUPPL 3)
12345